Banque Cantonale Vaudoise’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Banque Cantonale Vaudoise’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-327	Closed	-$38K	–	1227
2023 Q3	$38K	Hold	327	–	–	﹤0.01%	1002
2023 Q2	$34K	Sell	327 -40	-11%	-$4.22K	﹤0.01%	1013
2023 Q1	$40K	Sell	367 -4,233	-92%	-$468K	﹤0.01%	993
2022 Q4	$523K	Hold	4,600	–	–	0.03%	437
2022 Q3	$285K	Hold	4,600	–	–	0.02%	620
2022 Q2	$367K	Sell	4,600 -727	-14%	-$68.8K	0.02%	571
2022 Q1	$560K	Hold	5,327	–	–	0.02%	529
2021 Q4	$573K	Sell	5,327 -600	-10%	-$65.5K	0.02%	544
2021 Q3	$649K	Hold	5,927	–	–	0.03%	499
2021 Q2	$555K	Hold	5,927	–	–	0.02%	568
2021 Q1	$546K	Sell	5,927 -5,723	-49%	-$483K	0.03%	519
2020 Q4	$852K	Buy	11,650 +7,074	+155%	+$526K	0.05%	346
2020 Q3	$355K	Buy	4,576 +1,974	+76%	+$136K	0.02%	531
2020 Q2	$145K	Sell	2,602 -1,028	-28%	-$44K	0.01%	726
2020 Q1	$108K	Sell	3,630 -2,669	-42%	-$90.3K	0.01%	752
2019 Q4	$228K	Buy	+6,299	New	+$193K	0.02%	693

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $9.51B AUM 13.02% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.22B AUM 22.8% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Banque Cantonale Vaudoise's HZNP Position: Q4 2023 in Review

Banque Cantonale Vaudoise sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 327 shares — an estimated $38K sold.

Banque Cantonale Vaudoise first reported a position in HZNP in Q4 2019 and held it in 16 quarters. The position peaked at $852K in Q4 2020. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Banque Cantonale Vaudoise reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Banque Cantonale Vaudoise sold 327 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $38K.
Banque Cantonale Vaudoise first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2019 and held it in 16 quarters.
Banque Cantonale Vaudoise's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $852K in Q4 2020.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Banque Cantonale Vaudoise's 13F filing for Q4 2023, filed 7 Feb 2024.